companydata.dkcompanydata.dk
Back to company

Cell to Cure ApS: Financial statements 2020

CVR: 39401975

Cell to Cure ApS (CVR 39401975) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 523,178 and a net result of DKK 405,000. Equity amounted to DKK 461,770. The solvency ratio was 55%.

Gross Profit
523,178 kr.
Profit/Loss
405,000 kr.
Equity
461,770 kr.
Total Assets
839,135 kr.
Employees
0

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Cell to Cure ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

About Cell to Cure ApS

Cell to Cure ApS is a Danish company of the type Anpartsselskab based in Birkerød, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Cell2Cure ApS. The management consists of Martin Roland Jensen, Annette Ekblond and Jens Kastrup. The company's owners include MEDIC ADVICE ApS, Endeavour Cells ApS and Ekblond.ApS. In 2025, the company reported a gross profit of DKK -3,076,475 and a net result of DKK -9,792,604. Equity amounted to DKK -1,179,103.

Other financial years

2025202320222021